Trending...
- Mountain Fresh Water Systems Announces 5% End-of-Summer Discount on All Services
- Experience the Future: Tokenum Launches the First Gasless Swap on Ethereum, BSC, and Polygon
- Desert Outdoor Lighting Announces a 10% Discount for the Beginning of the Holiday Lighting Season
PUTNEY, U.K. - iSportsWire -- The Government's decision to axe free flu jabs for 50-64-year-olds has been called a false economy by a leading health testing expert. The free jab was introduced in 2020 to ease the burden on the NHS during Covid and had remained in place ever since. It means around 12 million Brits will no longer qualify for a jab. The decision to wind down targeted mpox (monkeypox) vaccinations this summer, despite a recent increase in cases, has also been criticised as short sighted.
Leading testing expert, Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, says: 'The axing of these two important vaccination campaigns represents a startlingly myopic decision by the Government, which could go on to have severe consequences. In terms of the ending of free Covid jabs for 50–65-year-olds, NHS England has been clear on its benefits, saying: "Flu immunisation is one of the most effective interventions we can provide to reduce harm from flu and pressures on health and social care services during the winter". Of most concern it also acknowledged that: "By preventing flu infection through vaccination, secondary bacterial infections such as pneumonia are prevented. This reduces the need for antibiotics and helps prevent antibiotic resistance."
More on iSports Wire
'Similarly, the Government has clearly been precipitous in ending its targeted monkeypox vaccinations campaign. The Government claimed in March that a sustained reduction in case numbers meant a targeted vaccine programme would no longer needed and could be wound down in the summer. However, the UK Health Security Agency (UKHSA) says that there have been a further 10 cases of monkeypox diagnosed in the UK since 4 May.
'The obvious conclusion is that the Government is cutting costs by axing free vaccines for groups of potentially at-risk people. This emphasis on money saving is even referred to in the latest statement of the Joint Committee on Vaccination and Immunisation (JVCI). Discussing flu vaccines, it stated in November: "JCVI is of the view that whilst there would be a clear health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective. As in recent years, JCVI supports vaccination in this group in principle if funding is available but remains concerned that it might not meet strict cost-effectiveness requirements and could divert from more cost-effective interventions." In other words, despite "clear health benefits" it's the Government's "strict cost-effectiveness requirements" that are taking precedence.
More on iSports Wire
'For anyone concerned about their potential lack of immunity to viruses, a general health test might be a useful course of action, to ensure they are in overall good health to help fight the symptoms of new viruses. For full details, see: https://www.londonmedicallaboratory.com/product/general-health
Leading testing expert, Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, says: 'The axing of these two important vaccination campaigns represents a startlingly myopic decision by the Government, which could go on to have severe consequences. In terms of the ending of free Covid jabs for 50–65-year-olds, NHS England has been clear on its benefits, saying: "Flu immunisation is one of the most effective interventions we can provide to reduce harm from flu and pressures on health and social care services during the winter". Of most concern it also acknowledged that: "By preventing flu infection through vaccination, secondary bacterial infections such as pneumonia are prevented. This reduces the need for antibiotics and helps prevent antibiotic resistance."
More on iSports Wire
- New NFL and NCAA Schools Join The Lineup For Second Annual Coach Knapp Stair Climb Initiative
- Michael Del Zotto Named All Access GTE's Global Ambassador of Sport
- Rhody Rug Revolutionizes Online Shopping Experience with the Launch of their New Direct-to-Consumer Website
- Long Island businessman turned recording artist, John Beyer, to release his first love song aptly titled, …"Love You More"
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
'Similarly, the Government has clearly been precipitous in ending its targeted monkeypox vaccinations campaign. The Government claimed in March that a sustained reduction in case numbers meant a targeted vaccine programme would no longer needed and could be wound down in the summer. However, the UK Health Security Agency (UKHSA) says that there have been a further 10 cases of monkeypox diagnosed in the UK since 4 May.
'The obvious conclusion is that the Government is cutting costs by axing free vaccines for groups of potentially at-risk people. This emphasis on money saving is even referred to in the latest statement of the Joint Committee on Vaccination and Immunisation (JVCI). Discussing flu vaccines, it stated in November: "JCVI is of the view that whilst there would be a clear health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective. As in recent years, JCVI supports vaccination in this group in principle if funding is available but remains concerned that it might not meet strict cost-effectiveness requirements and could divert from more cost-effective interventions." In other words, despite "clear health benefits" it's the Government's "strict cost-effectiveness requirements" that are taking precedence.
More on iSports Wire
- Exploring the World of Web3? Lympid Puts Users Front and Center
- "Regenerating Life": documentary film challenges current assumptions about climate change
- Flint's Got Talent Returns To Showcase Creativity In Community
- Autonomous eVTOLs $25 Billion Market by 2030
- Selling a Life Insurance Policy Might be a Better Option Than Letting it Lapse or Surrendering it
'For anyone concerned about their potential lack of immunity to viruses, a general health test might be a useful course of action, to ensure they are in overall good health to help fight the symptoms of new viruses. For full details, see: https://www.londonmedicallaboratory.com/product/general-health
Source: London Medical Laboratory
0 Comments
Latest on iSports Wire
- Crovetti Orthopaedics and Sports Medicine Introduces Infrared Medical Imaging to Its Diagnostic Offerings
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
- 5 Steps to an Exceptional Presentation
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Axiros ACS solution enables Earth Broadband to manage multiple client devices and CPE on AX69
- Art Exhibition - David Mackenzie: Outside the Lines
- Private Offices, Virtual Offices & Meeting Room in Calgary Alberta
- Dyson Williams, Adam Poitras, Callum Jones First Three Selections in 2023 NLL Draft
- From $100 Million to a Sporting Revolution: Zoom Call on the Future of Sports
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
- Desert Outdoor Lighting Announces a 10% Discount for the Beginning of the Holiday Lighting Season
- Mountain Fresh Water Systems Announces 5% End-of-Summer Discount on All Services
- Experience the Future: Tokenum Launches the First Gasless Swap on Ethereum, BSC, and Polygon
- Richard Dolan: Sports Visionary Joins NXXT Women's Pro Tour Advisory Board
- Namify's Innovative Organization Name Generator Redefines Branding
- TEDxTemecula presents 'Re-FORMing' – powerful ideas to shape the future
- Unlocking the Power of Strategic Partnerships in Brazil
- Experienced Voices™ Podcast Series Hosts Leading Entrepreneurs on Secrets to Success, What Entrepreneurs Need to Know
- Wohler launches iVAM-SUM and upgraded replacements for their AMP1-8-M & AMP1-16-M and VMQ-4 at IBC
- Tony Schulte Joins IntellaTriage as New Chief Operating Officer